Tiger Biotherapeutics Inc. — Form D
Tiger Biotherapeutics Inc. of CRANBURY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-05. The offering totals $22.0M, of which $20.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-04-05
- Form: D
- Accession: 0001972279-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $22.0M
- Amount sold: $20.0M
- Remaining: $2.0M
- Investors: 4
- Date of first sale: 2023-03-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-477994
Issuer
- Name: Tiger Biotherapeutics Inc.
- CIK: 0001972279
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 8 CLARKE DRIVE, SUITE 4, CRANBURY, NJ, 08512
- Phone: 646-462-5083
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| BIHUA CHEN | Director | Boston, MA |
| Jie FAN | Director | Cranbury, NJ |
| Quan ZHOU | Director | Rockville, MD |
| Jie FAN | Executive Officer | Cranbury, NJ |
More